Covered recipient · General Payments record
ENRIQUE IGLESIAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,014.18
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $575.07 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $268.37 | 18 |
| Lilly USA, LLC | $117.47 | 6 |
| Atland Pharmaceuticals, LLC | $63.48 | 1 |
| Acerta Pharma LLC | $30.33 | 2 |
| PFIZER INC. | $29.77 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $21.34 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.45 | 1 |
| Novo Nordisk AS | $15.09 | 1 |
| Amgen Inc. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.95 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964235 | CMS |
| ABBVIE INC. | $22.73 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964237 | CMS |
| ABBVIE INC. | $12.23 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964239 | CMS |
| ABBVIE INC. | $6.88 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964241 | CMS |
| ABBVIE INC. | $6.53 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964243 | CMS |
| ABBVIE INC. | $16.43 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964245 | CMS |
| ABBVIE INC. | $26.74 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964247 | CMS |
| ABBVIE INC. | $16.15 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964249 | CMS |
| ABBVIE INC. | $12.56 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964251 | CMS |
| ABBVIE INC. | $26.33 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964253 | CMS |
| ABBVIE INC. | $12.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964255 | CMS |
| ABBVIE INC. | $11.63 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964257 | CMS |
| ABBVIE INC. | $15.38 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964259 | CMS |
| ABBVIE INC. | $22.61 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964261 | CMS |
| ABBVIE INC. | $22.95 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964263 | CMS |
| ABBVIE INC. | $5.85 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964265 | CMS |
| ABBVIE INC. | $6.54 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964267 | CMS |
| ABBVIE INC. | $11.88 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964269 | CMS |
| Amgen Inc. | $13.77 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604766 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.88 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104413027 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.45 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104454908 | CMS |
| Atland Pharmaceuticals, LLC | $63.48 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067526571 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $21.34 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146778147 | CMS |
| Lilly USA, LLC | $15.45 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136169593 | CMS |
| Lilly USA, LLC | $15.75 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134966273 | CMS |
| Lilly USA, LLC | $26.57 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972613 | CMS |
| Lilly USA, LLC | $17.50 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136164658 | CMS |
| Lilly USA, LLC | $20.04 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972102 | CMS |
| Lilly USA, LLC | $22.16 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134972104 | CMS |
| Novo Nordisk Inc | $15.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097039019 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.45 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118911949 | CMS |
| PFIZER INC. | $13.62 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131845759 | CMS |
| PFIZER INC. | $16.15 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131981183 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.